JP2003526317A - 分泌蛋白およびそれらをコードするポリヌクレオチド - Google Patents

分泌蛋白およびそれらをコードするポリヌクレオチド

Info

Publication number
JP2003526317A
JP2003526317A JP2000527638A JP2000527638A JP2003526317A JP 2003526317 A JP2003526317 A JP 2003526317A JP 2000527638 A JP2000527638 A JP 2000527638A JP 2000527638 A JP2000527638 A JP 2000527638A JP 2003526317 A JP2003526317 A JP 2003526317A
Authority
JP
Japan
Prior art keywords
seq
sequence
polynucleotide
nucleotide
nucleotide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000527638A
Other languages
English (en)
Japanese (ja)
Inventor
ケネス・ジェイコブズ
ジョン・エム・マッコイ
エドワード・アール・ラバリー
リサ・エイ・コリンズ−レイシー
デイビッド・マーバーグ
モーリス・トレーシー
マイケル・ジェイ・アゴスティノ
ロバート・ジェイ・スタイニンガー・ザ・セカンド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLC filed Critical Genetics Institute LLC
Publication of JP2003526317A publication Critical patent/JP2003526317A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
JP2000527638A 1998-01-02 1998-12-31 分泌蛋白およびそれらをコードするポリヌクレオチド Withdrawn JP2003526317A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US7034698P 1998-01-02 1998-01-02
US60/070,346 1998-01-02
US22265398A 1998-12-30 1998-12-30
US09/222,653 1998-12-30
PCT/US1998/027903 WO1999035252A2 (fr) 1998-01-02 1998-12-31 Proteines secretees et polynucleotides les codant

Publications (1)

Publication Number Publication Date
JP2003526317A true JP2003526317A (ja) 2003-09-09

Family

ID=26751039

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000527638A Withdrawn JP2003526317A (ja) 1998-01-02 1998-12-31 分泌蛋白およびそれらをコードするポリヌクレオチド

Country Status (5)

Country Link
EP (1) EP1049770A1 (fr)
JP (1) JP2003526317A (fr)
AU (1) AU2210799A (fr)
CA (1) CA2316864A1 (fr)
WO (1) WO1999035252A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002018412A1 (fr) * 2000-08-28 2002-03-07 Human Genome Sciences, Inc. 17 protéines humaines sécrétées
WO2002014491A2 (fr) * 2000-08-10 2002-02-21 Pharmacia Corporation Nouvelle proteine de type facteur de croissance hematopoietique obtenue a partir d'une bibliotheque d'adnc d'une lignee cellulaire cytogene hs-5
GB0208925D0 (en) * 2002-04-12 2002-05-29 Univ Sheffield Polypeptide

Also Published As

Publication number Publication date
EP1049770A1 (fr) 2000-11-08
CA2316864A1 (fr) 1999-07-15
WO1999035252A2 (fr) 1999-07-15
AU2210799A (en) 1999-07-26

Similar Documents

Publication Publication Date Title
JP2001519667A (ja) 分泌発現配列タグ（ｓＥＳＴｓ）
JP2002537757A (ja) 分泌タンパク質及びそれらをコードするポリヌクレオチド
JP2003525575A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド
JP2002512517A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド
JP2002503955A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド
JP2001527403A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド
JP2003530296A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド
JP2001520033A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド
JP2002504488A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド
JP2001524490A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド
JP2002509722A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド
JP2003516709A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド
JP2001514520A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド
JP2002504822A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド
JP2002506611A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド
JP2002505870A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド
JP2003526317A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド
JP2003502004A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド
JP2001517941A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド
JP2002504306A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド
JP2003526318A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド
JP2002508936A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド
JP2002507390A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド
JP2002513280A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド
JP2002508655A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20060307